Literature DB >> 22483108

Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53.

Katia Zanier1, Abdellahi ould M'hamed ould Sidi, Charlotte Boulade-Ladame, Vladimir Rybin, Anne Chappelle, Andrew Atkinson, Bruno Kieffer, Gilles Travé.   

Abstract

The viral oncoprotein E6 is an essential factor for cervical cancers induced by "high-risk" mucosal HPV. Among other oncogenic activities, E6 recruits the ubiquitin ligase E6AP to promote the ubiquitination and subsequent proteasomal degradation of p53. E6 is prone to self-association, which long precluded its structural analysis. Here we found that E6 specifically dimerizes through its N-terminal domain and that disruption of the dimer interface strongly increases E6 solubility. This allowed us to raise structural data covering the entire HPV16 E6 protein, including the high-resolution NMR structures of the two zinc-binding domains of E6 and a robust data-driven model structure of the N-terminal domain homodimer. Interestingly, homodimer interface mutations that disrupt E6 self-association also inactivate E6-mediated p53 degradation. These data suggest that E6 needs to self-associate via its N-terminal domain to promote the polyubiquitination of p53 by E6AP.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22483108      PMCID: PMC3325491          DOI: 10.1016/j.str.2012.02.001

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  59 in total

1.  Treble clef finger--a functionally diverse zinc-binding structural motif.

Authors:  N V Grishin
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

2.  Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins.

Authors:  B A Glaunsinger; S S Lee; M Thomas; L Banks; R Javier
Journal:  Oncogene       Date:  2000-11-02       Impact factor: 9.867

3.  A sequence element of p53 that determines its susceptibility to viral oncoprotein-targeted degradation.

Authors:  J Gu; R M Rubin; Z M Yuan
Journal:  Oncogene       Date:  2001-06-14       Impact factor: 9.867

4.  A strategy for optimizing the monodispersity of fusion proteins: application to purification of recombinant HPV E6 oncoprotein.

Authors:  Y Nominé; T Ristriani; C Laurent; J F Lefèvre; G Travé
Journal:  Protein Eng       Date:  2001-04

5.  Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade.

Authors:  M Scheffner; U Nuber; J M Huibregtse
Journal:  Nature       Date:  1995-01-05       Impact factor: 49.962

6.  Formation of soluble inclusion bodies by hpv e6 oncoprotein fused to maltose-binding protein.

Authors:  Y Nominé; T Ristriani; C Laurent; J F Lefèvre; G Travé
Journal:  Protein Expr Purif       Date:  2001-10       Impact factor: 1.650

7.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

Authors:  P Schuck
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

8.  Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein.

Authors:  F Lipari; G A McGibbon; E Wardrop; M G Cordingley
Journal:  Biochemistry       Date:  2001-02-06       Impact factor: 3.162

9.  Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation.

Authors:  N A Farrow; R Muhandiram; A U Singer; S M Pascal; C M Kay; G Gish; S E Shoelson; T Pawson; J D Forman-Kay; L E Kay
Journal:  Biochemistry       Date:  1994-05-17       Impact factor: 3.162

10.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

View more
  56 in total

1.  Genetic variations in human papillomavirus and cervical cancer outcomes.

Authors:  Janet S Rader; Shirng-Wern Tsaih; Daniel Fullin; Miriam W Murray; Marissa Iden; Michael T Zimmermann; Michael J Flister
Journal:  Int J Cancer       Date:  2019-01-04       Impact factor: 7.396

Review 2.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

3.  Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR.

Authors:  Boya Zhang; Yinjing Song; Siyuan Sun; Rui Han; Chunting Hua; Stijn van der Veen; Hao Cheng
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

4.  HPV-mediated inactivation of tumor suppressor p53.

Authors:  Gilles Travé; Katia Zanier
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

5.  Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.

Authors:  Marcel Chris Conrady; Irina Suarez; Gergö Gogl; Desiree Isabella Frecot; Anna Bonhoure; Camille Kostmann; Alexandra Cousido-Siah; André Mitschler; JiaWen Lim; Murielle Masson; Thomas Iftner; Frank Stubenrauch; Gilles Travé; Claudia Simon
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

6.  Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex.

Authors:  Yuji Masuda; Yasushi Saeki; Naoko Arai; Hidehiko Kawai; Iwao Kukimoto; Keiji Tanaka; Chikahide Masutani
Journal:  J Biol Chem       Date:  2019-09-06       Impact factor: 5.157

7.  Human papillomavirus infection and biomarkers in sinonasal inverted papillomas: clinical significance and molecular mechanisms.

Authors:  Adam Scheel; Giant C Lin; Jonathan B McHugh; Christine M Komarck; Heather M Walline; Mark E Prince; Mark A Zacharek; Thomas E Carey
Journal:  Int Forum Allergy Rhinol       Date:  2015-06-16       Impact factor: 3.858

8.  Peptide interactions stabilize and restructure human papillomavirus type 16 E6 to interact with p53.

Authors:  Tina Ansari; Nicole Brimer; Scott B Vande Pol
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

9.  Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins.

Authors:  Katia Zanier; Sebastian Charbonnier; Abdellahi Ould M'hamed Ould Sidi; Alastair G McEwen; Maria Giovanna Ferrario; Pierre Poussin-Courmontagne; Vincent Cura; Nicole Brimer; Khaled Ould Babah; Tina Ansari; Isabelle Muller; Roland H Stote; Jean Cavarelli; Scott Vande Pol; Gilles Travé
Journal:  Science       Date:  2013-02-08       Impact factor: 47.728

Review 10.  The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.

Authors:  James A Scarth; Molly R Patterson; Ethan L Morgan; Andrew Macdonald
Journal:  J Gen Virol       Date:  2021-01-11       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.